To see the effect of hinguvadi vati in pain full menstruation.

Evaluation Of Antispasmodic Effect Of Hinguvadi Vati Over Shanka vati In Udavartini W.S.R To Primary Dysmenorrhoea In Adolescents- A Randomised Clinical Trial"

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014180

Enrollment

Registered

2018-05-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PAINFUL MENSTRUATION

Interventions

Intervention1: HINGUVADI VATI: Ingredients Hingu Amlavetasa Shunti Pippali Maricha Yavani Beejapuraka Saindhava lavana Sauvarchala lavana Vida lavana Dose-250 mg BD Route of adminisrtation-Oral Dur

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling Diagnostic criteria. Patients with regular menstrual cycle.

Exclusion criteria

Exclusion criteria: Known case of Secondary Dysmenorrhea Patients with any acute or chronic illness on medications, in whom interference with trial drug is anticipated based on history, will be excluded Patients having pain abdomen associated with menorrhagia metrorrhagia Known case hypothyroidism and hyperthyroidism with DUB Known case of congenital anomalies of uterus

Design outcomes

Secondary

Measure	Time frame
There may be significant effect of hinguvadi vati over shanka vati in primary dysmenorrheaTimepoint: 4 months	—

Primary

Measure	Time frame
Efficacy of the drug will be proven in reducing symptoms of Primary Dysmenorrhea in the given schedule dose and durationTimepoint: 0th and 3 rd day of every menstrual cycle for 3 consecutive cycles	—

Countries

India

Contacts

Public ContactSINDHU N

KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya

azizarbar@gmail.com9844532113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026